Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HPV, Human Papillomavirus Viruses, Human Papilloma Virus Vaccine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05247853
What this trial is testing

HPV Vaccine Effectiveness Study in Rwandan Women Living With HIV

Who this might be right for
Cervical CancerHuman Papilloma VirusHuman Immunodeficiency Virus+1 more
Montefiore Medical Center 3,127
Large-scale testing (Phase 3)Study completedNCT00947115
What this trial is testing

Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 525
Not applicableUnknownNCT04704908
What this trial is testing

Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls (54m)

Who this might be right for
Cervical Intraepithelial NeoplasiaCervical CancerVaginal Intraepithelial Neoplasia+2 more
Jun Zhang 979
Large-scale testing (Phase 3)Active Not RecruitingNCT04534205
What this trial is testing

A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1

Who this might be right for
Unresectable Head and Neck Squamous Cell CarcinomaMetastatic Head and Neck CancerRecurrent Head and Neck Cancer
BioNTech SE 358
Testing effectiveness (Phase 2)UnknownNCT03947775
What this trial is testing

HPV-SAVE_Merck_Sub-Study for Preventing Recurrence of HSIL

Who this might be right for
Anal Intraepithelial NeoplasiaAnal CancerHuman Papilloma Virus
University Health Network, Toronto 228
Not applicableStudy completedNCT01702337
What this trial is testing

Prevalence-based Health and Economic Model of the Bivalent Versus the Quadrivalent Human Papillomavirus (HPV) Vaccine

Who this might be right for
Human Papillomavirus Infection
GlaxoSmithKline 1
Large-scale testing (Phase 3)Active Not RecruitingNCT06632912
What this trial is testing

Phase IIIb Clinical Trial of Quadrivalent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) for Age/Immunization Schedule Bridging

Who this might be right for
Human Papillomavirus (HPV) InfectionHPV (Human Papillomavirus)-Associated Carcinoma
National Vaccine and Serum Institute, China 1,800
Not applicableStudy completedNCT00806676
What this trial is testing

Antibody Response to Human Papillomavirus Recombinant Vaccine (Gardasil®) in Girls and Young Women With Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease
Johns Hopkins University 67
Testing effectiveness (Phase 2)Looking for participantsNCT06686043
What this trial is testing

HPV Vaccine, Imiquimod, and Metformin Combination Trial

Who this might be right for
Cervical CarcinomaVaginal CarcinomaVulvar Carcinoma+1 more
Baylor College of Medicine 85
Large-scale testing (Phase 3)Study completedNCT00937950
What this trial is testing

Gynaecological Follow-up of a Subset of 580299/008 (NCT00122681) Study Subjects

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 2,022
Large-scale testing (Phase 3)Ended earlyNCT05584332
What this trial is testing

A Phase Ⅲ Study to Evaluate the Efficacy, Immunogenicity, Safety of Quadrivalent HPV Recombinant Vaccine in Chinese Healthy Females

Who this might be right for
Cervical CancerGenital WartCIN1+9 more
Shanghai Bovax Biotechnology Co., Ltd. 3,131
Not applicableStudy completedNCT01105000
What this trial is testing

Human Papilloma Virus (HPV) Knowledge and Attitudes and the Role of (SES) Socioeconomic Status and Ethnicity

Who this might be right for
HPV
Unity Health Toronto 160
Testing effectiveness (Phase 2)Study completedNCT00091130
What this trial is testing

SGN-00101 Vaccine in Treating Human Papillomavirus in Patients Who Have Abnormal Cervical Cells

Who this might be right for
Atypical Squamous Cells of Undetermined SignificanceCervical CancerHigh-grade Squamous Intraepithelial Lesion+1 more
National Cancer Institute (NCI) 139
Large-scale testing (Phase 3)Looking for participantsNCT05027776
What this trial is testing

Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 Years

Who this might be right for
HPV InfectionsCervical Cancer Stage IIaVaginal Cancer+4 more
Shanghai Bovax Biotechnology Co., Ltd. 1,348
Large-scale testing (Phase 3)Study completedNCT00849381
What this trial is testing

Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Brazil, Taiwan or Thailand

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 1,239
Not applicableLooking for participantsNCT04611022
What this trial is testing

Educate and Improve Underserved Populations' Uptake and Completion of the HPV Vaccine

Who this might be right for
Human Papilloma Virus
University of Colorado, Denver 1,000
Testing effectiveness (Phase 2)Study completedNCT00120848
What this trial is testing

Follow-up Study of GSK Biologicals' Human Papilloma Virus (HPV) Vaccine to Prevent Cervical Infection in Young Adults

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 776
Not applicableStudy completedNCT01908517
What this trial is testing

Human Papilloma Viruses (HPV) Vaccine Adherence Community Clinic Study

Who this might be right for
Patient Compliance
East Carolina University 522
Early research (Phase 1)Study completedNCT02405520
What this trial is testing

Safety and Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine

Who this might be right for
Condylomata Acuminata
Jun Zhang 145
Large-scale testing (Phase 3)Study completedNCT00578227
What this trial is testing

Evaluation of Safety and Immunogenicity of Co-administering Human Papillomavirus Vaccine With Another Vaccine in Healthy Female Subjects

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 814
Next Page